Edition:
India

SSY Group Ltd (2005.HK)

2005.HK on Hong Kong Stock

5.55HKD
17 Aug 2018
Change (% chg)

HK$-0.43 (-7.19%)
Prev Close
HK$5.98
Open
HK$6.20
Day's High
HK$6.26
Day's Low
HK$5.45
Volume
9,657,912
Avg. Vol
9,125,988
52-wk High
HK$9.46
52-wk Low
HK$3.25

Chart for

About

SSY Group Limited is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. Its products include finished medicines of intravenous infusion solution for hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s subsidiaries... (more)

Overall

Beta: 0.36
Market Cap(Mil.): HK$10,143.76
Shares Outstanding(Mil.): 2,849.37
Dividend: 0.03
Yield (%): 1.69

Financials

  2005.HK Industry Sector
P/E (TTM): 18.06 30.93 32.76
EPS (TTM): 0.20 -- --
ROI: 15.15 15.07 14.61
ROE: 20.15 16.59 16.33

BRIEF-Ssy Group Unit ‍Entered Agreement With Zhengzhou University For Research Of New Liver Fibrosis​ Drug

* UNIT ‍ENTERED AGREEMENT WITH ZHENGZHOU UNIVERSITY IN RELATION TO RESEARCH AND DEVELOPMENT OF NEW DRUG USED FOR LIVER FIBROSIS​

05 Mar 2018

BRIEF-SSY Group Updates On Development Of Hemofiltration Basic Solution

* GETS ‍APPROVAL FOR DRUG PRODUCTION AND REGISTRATION FOR HEMOFILTRATION BASIC SOLUTION (4000ML) FROM CHINA FOOD AND DRUG ADMINISTRATION​ Source text for Eikon: Further company coverage:

28 Feb 2018

BRIEF-Ssy Group Sees FY ‍Profit Attributable Up In Range Of 30 Pct To 40 Pct

* ‍PROFIT ATTRIBUTABLE FOR YEAR ENDED 31 DECEMBER 2017 IS EXPECTED TO INCREASE SIGNIFICANTLY RANGING FROM 30% TO 40%​

27 Feb 2018

Earnings vs. Estimates